Mehiläinen expands its rehabilitation services by acquiring Toimivax Oy and Neurokuntoutus NH Oy, enhancing its position as a leading provider in Finland.
Information on the Target
Mehiläinen has enhanced its therapy services through the acquisition of Toimivax Oy, operating in the Northern Ostrobothnia and Western Lapland regions, and Neurokuntoutus NH Oy, based in the capital area. The acquisition, effective October 1, 2025, reinforces Mehiläinen's nationwide network of rehabilitation services and deepens its expertise.
Both Toimivax and Neurokuntoutus come with recognized professionals in their respective fields, promising to complement and elevate the quality of services offered by Mehiläinen. With Toimivax’s strong local presence in Northern Finland and Neurokuntoutus's specialized knowledge in complex neurological rehabilitation, the integration of these organizations into Mehiläinen represents a strategic enhancement to service delivery.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
The Finnish rehabilitation services sector has been experiencing significant growth as demand for specialized therapeutic services continues to rise. The increasing prevalence of neurological conditions and th
Similar Deals
Novartis AG → Avidity Biosciences, Inc.
2026
Mehiläinen
invested in
Toimivax Oy and Neurokuntoutus NH Oy
in 2025
in a Merger deal